-
1
-
-
0013866340
-
Conventional and uveoscleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures
-
Bill A. Conventional and uveoscleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp. Eye Res. 51:1966;45-54
-
(1966)
Exp. Eye Res.
, vol.51
, pp. 45-54
-
-
Bill, A.1
-
2
-
-
0242500296
-
Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphological changes with age in Rhesus monkeys
-
Gabelt B.T., et al. Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphological changes with age in Rhesus monkeys. Invest. Ophthalmol. Vis. Sci. 44:2003;2118-2125
-
(2003)
Invest. Ophthalmol. Vis. Sci.
, vol.44
, pp. 2118-2125
-
-
Gabelt, B.T.1
-
3
-
-
0014707894
-
Effects of topically applied isoproterenol on aqueous humor dynamics in man
-
Ross R.A., Drance S.M. Effects of topically applied isoproterenol on aqueous humor dynamics in man. Arch. Ophthalmol. 83:1970;39-46
-
(1970)
Arch. Ophthalmol.
, vol.83
, pp. 39-46
-
-
Ross, R.A.1
Drance, S.M.2
-
4
-
-
0016293766
-
β-adrenergic responses in the eyes of rabbits, primates and man
-
Langham M.E., Diggs E. β-adrenergic responses in the eyes of rabbits, primates and man. Exp. Eye Res. 19:1974;281-295
-
(1974)
Exp. Eye Res.
, vol.19
, pp. 281-295
-
-
Langham, M.E.1
Diggs, E.2
-
6
-
-
0033044222
-
Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients
-
Toris C.B., et al. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am. J. Ophthalmol. 128:1999;8-14
-
(1999)
Am. J. Ophthalmol.
, vol.128
, pp. 8-14
-
-
Toris, C.B.1
-
7
-
-
0034754201
-
Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension
-
Woldemussie E., et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest. Ophthalmol. Vis. Sci. 42:2001;2849-2855
-
(2001)
Invest. Ophthalmol. Vis. Sci.
, vol.42
, pp. 2849-2855
-
-
Woldemussie, E.1
-
8
-
-
0017605449
-
Timolol: Dose response and duration of action
-
Zimmerman T.J., Kaufman H.E. Timolol: dose response and duration of action. Arch. Ophthalmol. 95:1977;605-607
-
(1977)
Arch. Ophthalmol.
, vol.95
, pp. 605-607
-
-
Zimmerman, T.J.1
Kaufman, H.E.2
-
9
-
-
0020026359
-
A new β-adrenergic blocking agent for treatment of glaucoma
-
Berriospi A.R., Leibowitz H.M. A new β-adrenergic blocking agent for treatment of glaucoma. Arch. Ophthalmol. 100:1982;943-946
-
(1982)
Arch. Ophthalmol.
, vol.100
, pp. 943-946
-
-
Berriospi, A.R.1
Leibowitz, H.M.2
-
10
-
-
0028863609
-
A double-masked, randomized 1-year study comparing Dorzolamide (Trusopt), Timolol and Betaxolol
-
Strahlman E., et al. A double-masked, randomized 1-year study comparing Dorzolamide (Trusopt), Timolol and Betaxolol. Arch. Ophthalmol. 113:1995;1009-1016
-
(1995)
Arch. Ophthalmol.
, vol.113
, pp. 1009-1016
-
-
Strahlman, E.1
-
11
-
-
0025022342
-
Chemical and pharmacological properties of MK927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route
-
Maren T.H., et al. Chemical and pharmacological properties of MK927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route. Exp. Eye Res. 50:1990;27-36
-
(1990)
Exp. Eye Res.
, vol.50
, pp. 27-36
-
-
Maren, T.H.1
-
12
-
-
0030030798
-
Trusopt, a topical carbonic anhydrase inhibitor
-
Donohue E.K., Wilensky J.T. Trusopt, a topical carbonic anhydrase inhibitor. J. Glaucoma. 5:1996;68-74
-
(1996)
J. Glaucoma
, vol.5
, pp. 68-74
-
-
Donohue, E.K.1
Wilensky, J.T.2
-
14
-
-
0033047027
-
2α metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension
-
2α metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension. Curr. Med. Res. Opin. 15:1999;87-93
-
(1999)
Curr. Med. Res. Opin.
, vol.15
, pp. 87-93
-
-
Nordmann, J.-P.1
-
15
-
-
0034744394
-
2α-isopropyl ester to latanoprost: A review of the development of xalatan
-
2α-isopropyl ester to latanoprost: a review of the development of xalatan. Invest. Ophthalmol. Vis. Sci. 42:2001;1134-1145
-
(2001)
Invest. Ophthalmol. Vis. Sci.
, vol.42
, pp. 1134-1145
-
-
Stjernschantz, J.1
-
16
-
-
0035203853
-
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist
-
Hellberg M.R., et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J. Ocul. Pharmacol. Ther. 17:2001;421-432
-
(2001)
J. Ocul. Pharmacol. Ther.
, vol.17
, pp. 421-432
-
-
Hellberg, M.R.1
-
17
-
-
0034766578
-
The pharmacology of bimatoprost (Lumigan™)
-
Woodward D.F., et al. The pharmacology of bimatoprost (Lumigan™). Surv. Ophthalmol. 45:2001;S337-S345
-
(2001)
Surv. Ophthalmol.
, vol.45
-
-
Woodward, D.F.1
-
18
-
-
0141430069
-
Morphological changes in the anterior eye segment after long term treatment with different receptor selective prostaglandin agonists and a prostamide
-
Richter M., et al. Morphological changes in the anterior eye segment after long term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest. Ophthalmol. Vis. Sci. 44:2003;4419-4426
-
(2003)
Invest. Ophthalmol. Vis. Sci.
, vol.44
, pp. 4419-4426
-
-
Richter, M.1
-
19
-
-
0034910110
-
2α-isopropyl ester treatment
-
2α-isopropyl ester treatment. Arch. Ophthalmol. 119:2001;1165-1170
-
(2001)
Arch. Ophthalmol.
, vol.119
, pp. 1165-1170
-
-
Gaton, D.D.1
-
20
-
-
0036905886
-
Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells
-
Anthony T., et al. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest. Ophthalmol. Vis. Sci. 43:2002;3705-3711
-
(2002)
Invest. Ophthalmol. Vis. Sci.
, vol.43
, pp. 3705-3711
-
-
Anthony, T.1
-
21
-
-
0037697095
-
2 agonist) on Cyr 61 and Connective Tissue Growth Factor gene expression
-
2 agonist) on Cyr 61 and Connective Tissue Growth Factor gene expression. J. Biol. Chem. 278:2003;27267-27277
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 27267-27277
-
-
Liang, Y.1
-
22
-
-
0037370463
-
Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost
-
Gandolfi S.A., Cimino L. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology. 110:2003;609-614
-
(2003)
Ophthalmology
, vol.110
, pp. 609-614
-
-
Gandolfi, S.A.1
Cimino, L.2
-
23
-
-
0037404481
-
Pharmacological characterization of a novel anti-glaucoma agent, bimatoprost (AGN 192024)
-
Woodward D.F., et al. Pharmacological characterization of a novel anti-glaucoma agent, bimatoprost (AGN 192024). J. Pharmacol. Exp. Ther. 305:2003;772-785
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.305
, pp. 772-785
-
-
Woodward, D.F.1
-
24
-
-
0035824702
-
Bimatoprost and its free acid are prostaglandin FP receptor agonists
-
Sharif N.A., et al. Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur. J. Pharmacol. 432:2001;211-213
-
(2001)
Eur. J. Pharmacol.
, vol.432
, pp. 211-213
-
-
Sharif, N.A.1
-
25
-
-
0035957553
-
Exploring the potential for subtype-selective muscarinic agonists in glaucoma
-
Gil D.W., et al. Exploring the potential for subtype-selective muscarinic agonists in glaucoma. Life Sci. 68:2001;2601-2604
-
(2001)
Life Sci.
, vol.68
, pp. 2601-2604
-
-
Gil, D.W.1
-
26
-
-
0032725983
-
Is neuroprotection a viable therapy for glaucoma?
-
Weinreb R.N., Levin L.A. Is neuroprotection a viable therapy for glaucoma? Arch. Ophthalmol. 117:1999;1540-1544
-
(1999)
Arch. Ophthalmol.
, vol.117
, pp. 1540-1544
-
-
Weinreb, R.N.1
Levin, L.A.2
-
27
-
-
0035082121
-
Various concentrations of topically applied brimonidine tartrate 0.2%
-
Kent A.R., et al. Various concentrations of topically applied brimonidine tartrate 0.2%. Ophthalmology. 108:2001;784-787
-
(2001)
Ophthalmology
, vol.108
, pp. 784-787
-
-
Kent, A.R.1
-
28
-
-
0035198185
-
Alpha2-adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia
-
Donello J.E., et al. Alpha2-adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J. Pharmacol. Exp. Ther. 296:2001;216-223
-
(2001)
J. Pharmacol. Exp. Ther.
, vol.296
, pp. 216-223
-
-
Donello, J.E.1
-
29
-
-
0032879302
-
Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
-
Osborne N.N., et al. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp. Eye Res. 69:1999;331-342
-
(1999)
Exp. Eye Res.
, vol.69
, pp. 331-342
-
-
Osborne, N.N.1
-
30
-
-
0033578378
-
Inhibition of nitric oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
-
Neufeld A.H., et al. Inhibition of nitric oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9944-9948
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 9944-9948
-
-
Neufeld, A.H.1
-
31
-
-
0036913245
-
Neuroprotective effect of memantine in different retinal injury models in rats
-
Woldemussie E., et al. Neuroprotective effect of memantine in different retinal injury models in rats. J. Glaucoma. 11:2002;474-480
-
(2002)
J. Glaucoma
, vol.11
, pp. 474-480
-
-
Woldemussie, E.1
-
32
-
-
0019445529
-
Fluorophotometric study of epinephrine and timolol in human subjects
-
Schenker H.I., et al. Fluorophotometric study of epinephrine and timolol in human subjects. Arch. Ophthalmol. 99:1981;1212-1216
-
(1981)
Arch. Ophthalmol.
, vol.99
, pp. 1212-1216
-
-
Schenker, H.I.1
-
33
-
-
0035163062
-
Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics
-
Brubaker R.F., et al. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am. J. Ophthalmol. 131:2001;19-24
-
(2001)
Am. J. Ophthalmol.
, vol.131
, pp. 19-24
-
-
Brubaker, R.F.1
|